1-Y-E1-1 YIAApplicability of “NORD-1,” a light-reactive NO releaser, to the lower urinary
tract dysfunction
Kotomi Maeda1, Yuji Hotta1, Naoya Ieda2, Tomoya Kataoka3, Hidehiko Nakagawa2,Kazunori Kimura1,3
1

Dept. Hospital Pharm., Grad. Sch. Pharm. Sci., Nagoya City Univ., 2Dept. Organic & Medicinal Chem., Grad. Sch.
Pharm. Sci., Nagoya City Univ., 3Dept. Clinical Pharm., Grad. Sch. Med. Sci., Nagoya City Univ.

Copyright © The Japanese Pharmacological Society1-Y-E1-2 YIAHigh salt diet enhanced cholinergic components-induced contractile
responses of detrusor muscle in Dahl salt-sensitive rats
Ryoya Kawata1, Yuji Hotta1, Kotomi Maeda1, Tomoya Kataoka2, Kazunori Kimura1,21

Dept. Hospital Pharm., Grad. Sch. Pharm. Sci., Nagoya City Univ., 2Dept. Clinical Pharm., Grad. Sch. Med. Sci.,
Nagoya City Univ.

Copyright © The Japanese Pharmacological Society1-Y-E1-3 YIAGeneration of novel hypertension-diabetic nephropathy mice model andameliorative effect of PDE 4 and 5 inhibitors.
Yasunori NioTakeda Pharmaceutical Company

Copyright © The Japanese Pharmacological Society1-Y-E1-4 YIAAcute kidney injury-induced ZBTB38 contributes to tubular cell loss.
Takeo Harada1, Masanori Obana1, Yosiaki Miyake1, Ayaha Yamamoto1, Hiroyasu Kamuro1,Syota Tanaka1, Makiko Maeda1,2, Yasushi Fujio1,21

Laboratory of Clinical Science and Biomedicine, Grad. Sch. Pharm., Osaka Univ., 2Laboratory of ClinicalPharmacology and Therapeutics, Grad. Sch. Pharm., Osaka Univ.

Copyright © The Japanese Pharmacological Society1-Y-E2-1 YIA
Effects of various 5-HT3 receptor antagonists on cisplatin-induced acutekidney injury131,211Masaya Kanda , Mitsuhiro Goda , Toshihiko Yoshioka , Ami Yoshida , Takahiro Nimura ,1,24322Yoshito Zamami , Yuki Ishizawa , Kenta Yagi , Hirohumi Hamano , Naoto Okada ,1,2Keisuke Ishizawa
1

Dept. Clin. Pharmacol. Ther., Grad. Sch. Biomed. Sci., Tokushima Univ.,,2Dept. Pharm., Tokushima Univ. Hosp.,,
3Clin. Res. Ctr. Dev. Ther., Tokushima Univ. Hosp.,,4AWA Support Ctr, Tokushima Univ.,

Copyright © The Japanese Pharmacological Society1-Y-E2-2 YIA
A drug repositioning approach against cisplatin-induced nephrotoxicity.
Eri Wakai, Yuya Suzumura, Yuhei Nisimura
Department of Integrative Pharmacology, Mie University Graduate School of Medicine

Copyright © The Japanese Pharmacological Society1-Y-E2-3 YIA
Vitamin E induces palmitoylation of 67kDa laminin receptor by directbinding .
Seika Okamoto1, Daiki Hayashi1,2, Naoko Adachi3, Mouchlis Varnavas2, Shuji Ueda1,Minoru Yamanoue1, Dennis Edward2, Toshiki Ito3, Naoaki Saito3, Yasuhito Shirai1
1Dept. of Appl. Chem.in Biosci.,Kobe Univ., 2Dept. of Chem.,UCSD, 3Biosignal Res. Ctr.,Kobe Univ.

Copyright © The Japanese Pharmacological Society1-Y-E2-4 YIAHMG-CoA reductase inhibitor ameliorate oxaliplatin-induced peripheral
neuropathy via GST in peripheral neuron
Fuka Aizawa1, Yoshito Zamami1,2, Takahiro Niimura2, Takehiro Kawashiri3, Mitsuhiro Goda4,Kenta Yagi4, Yuki Izawa-Ishizawa5, Keisuke Ishizawa1,2
1

Department of Pharmacy, Tokushima University Hospital, 2Department of Clinical Pharmacology andTherapeutics, Tokushima University Graduate School of Biomedical Sciences, 3Department of Clinical Pharmacy
and Pharmaceutical Care, Graduate School of Pharmaceutical Sciences, Kyushu University, 4Clinical ResearchCenter for Developmental Therapeutics, Tokushima University Hospital, 5AWA Support Center, Tokushima
University

Copyright © The Japanese Pharmacological Society1-Y-E3-1 YIA
Therapeutic potency and mechanisms of polyI:C in triple negative breast
cancerTamura Yusuke, Masato Morikawa, Ryo Tanabe, Daizo Koinuma, Kohei Miyazono
Dept. Mol. Path., Grad. Sch. Med., Univ. Tokyo

Copyright © The Japanese Pharmacological Society1-Y-E3-2 YIA
Biological significance of CYLD downregulation in Triple negative breast
cancer.
Kuwano Akari1, Chika Hirai1, Naoki Suenaga1, Ayumi Kanemaru1, Hitomi Arakaki1,Mitsuhiro Hayashi2, Chika Saigou1,3, Hideyuki Saitou1,3, Hirofumi Jono1,31

Dept. Clinical Pharmaceutical Sciences, Kumamoto Univ. Grad. Sch. Pharm., 2Dept. Breast and Endocrine
Surgery, Kumamoto Univ. Grad. Sch. Med., 3Dept. Pharm. Kumamoto Univ.

Copyright © The Japanese Pharmacological Society1-Y-E3-3 YIA
Development of a novel epitope mapping method (REMAP) using RIEDL tagsystem
Asano Teizo, Mika Kaneko, Yukinari Kato
Dept. Antibody Drug Development, Tohoku University Grad. Sch. of Med.

Copyright © The Japanese Pharmacological Society1-Y-E3-4 YIA
Construction of biologically-interpretable chemical–disease association
focused on transcription factors organizing chemically-perturbed genes
Zou Zhaonan1, Michio Iwata2, Yoshihiro Yamanishi2, Shinya Oki1
1

Dept Drug Discov Med, Grad Sch Med, Kyoto Univ, 2Dept Biosci Bioinform, Fac Comp Sci Syst Eng, Kyushu Inst
TechCopyright © The Japanese Pharmacological Society1-Y-F1-1 YIA
Chronic social defeat stress induces depression-like behavior through thedecrease of GLT-1 ubiquitination in the mouse prefrontal cortex.
Aika Kosuge1, Kazuo Kunisawa1, Tsubasa Iida1, Bolati Wulaer2,3, Willy Jaya Suento3,4,Yasuko Yamamoto3, Kuniaki Saito2,3,5, Akihiro Mouri1,5, Toshitaka Nabeshima2,51

Dept. Regulatory Sci., Grad. Sch. Health Sci., Fujita Health Univ., 2Adv. Diagnostic. Syst. Res. Lab., Grad. Sch.
Health Sci., Fujita Health Univ., 3Dept. Disease Control & Prevention., Grad. Sch. Health Sci., Fujita Health Univ.,
4
Dept. Psychiatry., Fac. Med., Hasanuddin Univ., 5NPO. J-DO.

Copyright © The Japanese Pharmacological Society1-Y-F1-2 YIA
Induction of resilience for social stress mediating increased BDNF in thestriatum by Shati/Nat8l
Hajime Miyanishi1, Shin-ichi Muramatsu2,3, Atsumi Nitta1
1

Dept of Pharm Therap and Neuropharmcol, Fact of Pharmaceut Sci, Grad Univ of Med and Pharm Sci, Univ ofToyama, 2Div of Neuro Gene Therap, Open Innov Ctr, Univ of Jichi Med, 3Ctr for Gene & Cell Therap, Ins of Med
Sci, Univ of Tokyo

Copyright © The Japanese Pharmacological Society1-Y-F1-3 YIA
Subtype-specific dynamics and roles for chronic stress-inducedmobilization of leukocytes
Ishikawa Yuka1,2, Shiho Kitaoka1, Taro Kato2, Tomoyuki Furuyashiki1
1Div. of Pharmacol., Grad. Sch. of Med., Kobe Univ., 2Pharmacol. Res. Unit, Sumitomo Dainippon Pharma Co.,Ltd.

Copyright © The Japanese Pharmacological Society1-Y-F1-4 YIA
Kamikihito enhances cognition and improves anhedonia-like traits in aged
C57BL/6J mice
Hiroaki Oizumi, Shinji Miyazaki, Yuji Omiya, Yoshiki Ikeda
Tsumura Kampo Research Laboratories, Tsumura & Co.

Copyright © The Japanese Pharmacological Society1-Y-F2-1 YIA
Selective δ-opioid receptor agonist, KNT-127, facilitates extinction learningof contextual fear via fear circuitry in mice.
Ayako Kawaminami1, Daisuke Yamada1, Shoko Yanagisawa1, Motoki Shirakata1, Keita Iio2,Hiroshi Nagase2, Akiyoshi Saitoh1
1Lab Pharmacol, Fac Pharm Sci, Tokyo Univ of Science, 2IIIS, Univ of Tsukuba

Copyright © The Japanese Pharmacological Society1-Y-F2-2 YIA
Reactivation of hippocampal place cells in reward and sleep
Saichiro Yagi1, Yuji Ikegaya1,2,3, Takuya Sasaki1,41

Lab. Chem. Pharmacol., Grad. Sch. Pharmaceut. Sci., Univ. Tokyo, 2Institute for AI and Beyond, The University ofTokyo, 3Center for Information and Neural Networks, National Institute of Information and Communications
Technology, 4Precursory Research for Embryonic Science and Technology

Copyright © The Japanese Pharmacological Society1-Y-F2-3 YIA
NOX1/NADPH oxidase regulates compulsive-like repetitive behaviors
through promoting D2 receptor-mediated synaptic facilitation in the striatum
112

1

Nozomi Asaoka , Masakazu Ibi , Shuji Kaneko , Chihiro Yabe
1

Dept. Pharmacol., Grad. Sch. Med., Kyoto Pref. Univ. Med., 2Dept. Mol. Pharm., Grad. Sch. Pharm. Sci., KyotoUniv.

Copyright © The Japanese Pharmacological Society1-Y-F2-4 YIAHigh salt intake induces hypertension and abnormal behaviors withperipheral inflammatory responseHisayoshi Kubota1, Akihiro Mouri1,6, Kazuo Kunisawa1, Masaya Hasegawa1, Hitomi Kurahashi1,
Yasuko Yamamoto2, Hiroyuki Tezuka3, Masanori Kugita4, Shizuko Nagao4, Kuniaki Saito2,5,6,
Toshitaka Nabeshima5,61

Dept. Regulatory Sci., Grad. Sch. Health Sci., Fujita Health Univ., 2Dept. Disease Control & Prevention., Grad.
Sch. Health Sci., Fujita Health Univ., 3Res. Promotion & Support Headquarters., Fujita Health Univ., 4Educ & Res.
Ctr. Anim. Models. Hum. Diseases., Fujita Health Univ., 5Adv. Diagnostic. Syst. Res. Lab., Grad. Sch. Health Sci.,
Fujita Health Univ., 6NPO. J-DO

Copyright © The Japanese Pharmacological Society1-Y-F3-1 YIA
Involvement of amygdalar NPY and glutamatergic functions in impaired
social behavior in diabetic miceNaomi Yonemochi1, Daiki Ueda1, Tomohiro Kamata1, Junzo Kamei2, Hiroko Ikeda1
1

Dept. Pathophysiol. Ther., Hoshi Univ. Sch. Pharm. Pharmaceut. Sci., 2Dept. Biomol. Pharmacol., Hoshi Univ.
Sch. Pharm. Pharmaceut. Sci.

Copyright © The Japanese Pharmacological Society1-Y-F3-2 YIA
NOX1/NADPH oxidase affects the development of autism-like behaviors in amaternal immune activation model
Xueqing Zhang, Masakazu Ibi, Chihiro Yabe-NishimuraDept. Pharmacol. Kyoto Prefectural University of Medicine

Copyright © The Japanese Pharmacological Society1-Y-F3-3 YIAChildcare behavior study using computer vision and deep learning analysis
Sajjaviriya Chortip, Morio Azuma, Hiroyoshi Tsuchiya, Taka-aki Koshimizu
Div. Mol. Pharmacol., Jichi Med. Univ.

Copyright © The Japanese Pharmacological Society1-Y-F3-4 YIAEffects of a Rho-kinase inhibitor, fasudil on schizophrenia-like behavior andneurotransmitter release in MK-801-treated miceRinako Tanaka1, Masahito Sawahata1, Saeko Takase1, Yue Liu1, Kazuhiro Hada1,Hiroyuki Mizoguchi1, Taku Nagai1, Toshitaka Nabeshima2, Norio Ozaki3, Kiyofumi Yamada1
1

Dept. Neuropsychopharmacol. Hosp. Pharm., Nagoya Univ. Grad. Sch. Med., Nagoya, Japan, 2Adv. Diag. Sys. Res.
Lab., Grad. Sch. Health Sci., Fujita Health Univ., Toyoake, Japan, 3Dept. Psychiatry, Nagoya Univ. Grad. Sch.
Med., Nagoya, Japan

Copyright © The Japanese Pharmacological Society